Baby diaper manufactureR B A B Y D I A P E R M A N U FA C T U R E R P P N O N W O V E N M U L T I L A Y E R S • Provide slip additives with high concentrated content • Offer products meeting customer FDA requirements • Shorten supply lead time and reduce cost compared with importing from EU • Offered additives with high concentrated content, which is unachievable for competitors • Provided regulatory support, significant cost and time savings • Compressed the timeline through on-site color visualization, exploration, and formulation of new colors by the expert designer Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT?

Medical gown manufacturer M E D I C A L G OW N M A N U FAC T U R E R P P N O N W O V E N M U L T I L A Y E R S • Excellent anti-microbial and anti-virus performance • Pass JIS Test • Provide technical support including specific specs, processing and molding recommendations • Customized anti-virus solutions designed to support performance standards for materials used in the surgical environment • Provided technical support for material selection, part & tool design, and process development to accelerate commercialization • Supported customer’s products pass the JIS test Cesa WithStand Antimicrobial Additives KEY REQUIREMENTS WHY AVIENT?

FA B R I C A N T E DE E M B AL AG E N S FA R M AC Ê U T I C AS G A R R A F A S Â M B A R • Garantir a conscientização sobre os padrões e requisitos de conformidade aplicáveis • Fornecer opções de matéria-prima que estejam alinhadas com os padrões brasileiros de embalagens farmacêuticas • Aderir às Boas Práticas de Fabricação (BPF) • Colaborou em toda a cadeia de suprimentos para garantir que as necessidades regulatórias de matéria-prima fossem atendidas • Avaliação da conformidade das matérias- primas com os padrões brasileiros de embalagens farmacêuticas • Material produzido sob os requisitos de BPF Hiformer Liquid Masterbatches PRINCIPAIS REQUISITOS POR QUE A AVIENT?

Heavy Truck manufacturer HEAVY TRUCK MANUFACTURER E X T E R I O R S T E P P E D A L • Offer pre-color support to achieve an approved silver color formulation • Provide a metallic look with good weather resistance and wear performance for the exterior part • Shorten development time to gain durability approval • Offered color options that met desired metal color and texture, which was different from an ordinary plastic feel • Achieved excellent wear performance and weather resistance, qualifying it to replace metal • Provided support in achieving durability approval, resulting in significant time and cost savings OnForce Long Glass Fiber Reinforced Polypropylene Composites KEY REQUIREMENTS WHY AVIENT?

S I D IN G & C LA D D I N G M A N U FAC T U R E R P R O F I L E E X T R U S I O N • Achieve consistent distribution and uniform cell structure • Avoid adverse chemical reactions caused by material incompatibility with PVC formulations • Maintain impact resistance and durability • Attain thermally-stable chemical foaming agent (CFA) and gas decomposition temperatures to avoid manufacturing downtime • Ensure the integrity of color, finish, and aesthetics • Validated performance and compatibility during formulation and testing to confirm material compatibility and consistency • Established processing parameters for real- time precision in temperature, pressure, and extrusion speed • Optimized CFA and process to balance weight reduction and retain mechanical properties and aesthetics Hydrocerol Chemical Foaming Agents KEY REQUIREMENTS WHY AVIENT?

PowerPoint Presentation M E D I C A L D E V I C E M A N U FA C T U R E R O S T O M Y B A G S E A L S • Comply with ISO 10993 and FDA Class II medical device regulations • Offer Good sealing performance • Provide technical supports for processing recommendations • Deliver a high compression set materials to improve comfort • Provided a medical-grade TPE to help the customer meet necessary regulatory specifications and gain market share • Provided technical support during design and the manufacturing process for EVA bonding • Delivered soft-touch feel and excellent sealing performance Versaflex HC Thermoplastic Elastomers - G2705 Formulation KEY REQUIREMENTS WHY AVIENT?

F L E X IB L E PA C K AG I N G M A N U FAC T U R E R F L E X I B L E P O U L T R Y P A C K A G I N G • Provide low friction resistance for multilayer film structures with external polyamides • Prevent self-adhesion of plastic films • Enhance the end-use appearance • Provided additives that result in a lower coefficient of friction for packaging end products • Enhanced the appearance of packaging surfaces by creating a smoother finish • Offered expertise in additives for polyamides in flexible packaging and assistance in achieving regulatory approval Cesa Anti-Block Additives and Cesa Slip Additives KEY REQUIREMENTS WHY AVIENT?

utm_source=eBook&utm_id=rPET Button 92: Button 93: Button 3: Button 83: Button 5: Button 6: Button 66: Button 67: Button 68: Button 69: Button 70: Button 71: Button 72: Button 73: Button 74: Button 75: Button 76: Button 77: Button 78: Button 79: Button 84: Button 85: Button 86: Button 87: Button 88: Button 89: Button 90: Button 91: Button 80:

Use of Non-GAAP Measures Page 3 PolyOne Commodity to Specialty Transformation • Volume driven, commodity producer • Heavily tied to cyclical end markets • Performance largely dependent on non- controlling joint ventures 2000-2005 2006 - 2009 2010 – 2014 2015 and beyond • Steve Newlin appointed, Chairman, President and CEO • New leadership team appointed • Implementation of four pillar strategy • Focus on value based selling, investment in commercial resources and innovation to drive transformation • 18 consecutive quarters of double- digit adjusted EPS growth • Shift to faster growing, high margin, less cyclical end markets • Key acquisitions propel current and future growth, as well as margin expansion • Established aggressive 2015 targets • Continue specialty transformation • Targeting $2.50 Adjusted EPS by 2015, nearly double 2013 EPS • Drive double digit operating income and adjusted EPS growth Confirmation of Our Strategy The World’s Premier Provider of Specialized Polymer Materials, Services and Solutions Specialization Globalization Operational Excellence Commercial Excellence -150.00% -50.00% 50.00% 150.00% 250.00% 350.00% 450.00% PolyOne S&P 500 Russell 2000 Dow Jones Chemical All time high of $39.28 April 4th, 2014 • 18 consecutive quarters of double digit EPS growth • 49% CAGR adjusted EPS expansion 2006-2013 • 2013 stock price increased 73% versus 30% growth in the S&P • More than seven fold increase in market cap: $0.5b $3.6b Strategy and Execution Drive Results Page 6 Appliance 4% Building & Construction 13% Wire & Cable 9% Electrical & Electronics 5% Consumer 10%Packaging 16% Industrial 12% HealthCare 11% Transportation 18% Misc. 2% 0.12 0.27 0.21 0.13 0.68 0.82 1.00 1.31 2.50 $0.00 $0.25 $0.50 $0.75 $1.00 $1.25 $1.50 $1.75 $2.00 $2.25 $2.50 2006 2007 2008 2009 2010 2011 2012 2013 2015 Target A dj us te d Ea rn in gs P er S ha re 2013 Revenues: $3.8 Billion End Markets 2013 Revenues: $3.8 Billion EPS Page 7 PolyOne At A Glance United States 67% Europe 14% Canada 7% Asia6% Latin America 6% Specialty 54% PP&S 18% Distribution 28% Mix Shift Highlights Specialty Transformation Page 8 Old PolyOne Transformation *Operating Income excludes corporate charges and special items 2% 34% 43% 62% 64% 0% 20% 40% 60% 80% 100% 2005 2008 2010 2013 Q1 2014 2015 % o f O pe ra tin g In co m e* JV's Performance Products & Solutions Distribution Specialty 65-75% Specialty OI $5M $46M $87M $195M $60M Target 2015 Target Proof of Performance & 2015 Goals Page 9 2006 Q1 2014 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 13.8% 12 – 16% Global Specialty Engineered Materials 1.1% 11.6% 12 – 16% Designed Structures & Solutions -- 6.5% 8 – 10% Performance Products & Solutions 5.5% 7.7% 9 – 12% Distribution 2.6% 6.1% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 64% 65 – 75% 3) ROIC* (after-tax) 5.0% 9.4% 15% 4) Adjusted EPS Growth N/A 42% Double DigitExpansion *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period Bridge to $2.50 Adjusted EPS by 2015 2015 EPS: $2.50 2013 EPS: $1.31 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental share buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid single digit revenue CAGR Innovation Drives Earnings Growth $20.3 $52.3 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years Page 11 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 42.0% 2006 Q1 2014 Healthcare Consumer Packaging and Additive Technology Transportation Page 12 Unique and Innovative Solutions https://www.dropbox.com/sh/dwe4t8aacvhb8ui/uD3p_bdglP/Presentation revise pics/GLS Beverage can closure XO 2.jpg https://www.dropbox.com/sh/dwe4t8aacvhb8ui/-YgkycKypw/Anti-Counterfeiting release & images/GN1979.JPG 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 3/31/2014 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Investing in operational and initiatives that drive profitability growth  Manufacturing realignment  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

The amount of naturally occurring water present in meat is around 60–70%.